Evaluation of pain during breast injury nonpalpable realization of achievement with blue patent
Keywords:
Breast neoplasms, Coloring agents, Biopsy, Mammography, Early detection of cancerAbstract
Objective: To evaluate pain during the marking of impalpable breast lesions with the use of patent blue dye through an analog pain scale. Methods: The study included 50 patients treated between 2012 and 2015. These had impalpable breast lesions with image diagnosis by mammography and ultrasound or breast. On the day of surgery, marking with the blue dye was made and, before the procedure, patients were instructed to report the perceived pain after surgery by visual pain scale ranging from 0 (no pain) to 10 (worst pain). Results: Of the 50 patients studied, 1 was dismissed by experience allergic reactions. The average age was 50.3 years. The average pain during the marking was 5.13±2.84. When the labeling was done with ultrasound, the average pain was 2.8±4.68, whereas mammography showed 7.38±1.99 (p=0.02). With respect to cancer, it was observed that 7 patients with cancer pain had a mean of 5.43±3.2, while the others reported an average pain of 5.07±2.72 (p=0.769). When analyzing the pain in relation to age, it is clear that pain is the highest average of 6.08±2.43 (p=0.465), reported by patients over 60 years. Conclusion: Patients who undergo marking nonpalpable lesions experience significant pain, especially if the identification is made by means of mammography. Therefore, it is recommended in this group use procedures that reduce discomfort, such as the use of topical anesthetic.
Downloads
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.